bf/NASDAQ:MCRB_icon.jpeg

COM:SERESTHERAPEUTICS

Seres Therapeutics, Inc.

  • Stock

USD

Last Close

0.73

22/11 21:00

Market Cap

149.43M

Beta: -

Volume Today

1.58M

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
net income
-6.10M
-
-16.71M
173.83%
-54.78M
227.85%
-91.58M
67.18%
-89.38M
2.40%
-98.94M
10.70%
-70.28M
28.97%
-89.13M
26.82%
-65.58M
26.42%
-250.16M
281.46%
-113.72M
54.54%
depreciation and amortization
88K
-
190K
115.91%
728K
283.16%
4.21M
477.61%
7.26M
72.63%
7.86M
8.31%
7.60M
3.29%
6.58M
13.48%
5.95M
9.59%
6.63M
11.47%
15.11M
128.00%
deferred income tax
8K
-
1.42M
17,625%
7K
99.51%
103K
-
2.53M
-
-114.23M
-
stock based compensation
209K
-
2.07M
889.47%
9.69M
368.76%
16.86M
73.89%
17.36M
3.00%
16.64M
4.15%
8.34M
49.86%
8.82M
5.75%
20.22M
129.17%
25.48M
26.01%
34.10M
33.82%
change in working capital
457K
-
2.28M
398.25%
3.14M
37.90%
114.82M
3,556.82%
-10.55M
109.19%
11.80M
211.83%
-24.63M
308.72%
-23.20M
5.81%
41.53M
279.03%
-18.39M
144.28%
-58.98M
220.68%
accounts receivables
-1.78M
-
-7.60M
325.88%
9.39M
223.48%
-8.67M
-
inventory
-3.86M
-
-2.87M
25.66%
27.14M
1,045.25%
-29.65M
-
accounts payables
281K
-
810K
188.26%
2.68M
231.11%
3.58M
33.52%
-856K
123.90%
-353K
58.76%
-1.46M
313.60%
-1.16M
20.62%
9.36M
907.77%
2.20M
76.47%
-11.58M
625.56%
other working capital
176K
-
1.47M
733.52%
458K
68.78%
111.24M
24,188.86%
-9.70M
108.72%
12.15M
225.34%
-17.52M
244.17%
-11.56M
33.99%
-4.36M
62.33%
-20.59M
372.66%
-9.08M
55.92%
other non cash items
19K
-
398K
1,994.74%
367K
7.79%
-386K
205.18%
-213K
44.82%
-214K
0.47%
2.34M
1,191.59%
3.31M
41.78%
2.04M
38.38%
7.62M
273.40%
120.36M
1,479.32%
net cash provided by operating activities
-5.32M
-
-10.36M
94.66%
-40.84M
294.32%
43.92M
207.53%
-75.52M
271.95%
-62.85M
16.78%
-76.52M
21.74%
-93.61M
22.33%
6.69M
107.14%
-228.82M
3,521.29%
-117.35M
48.71%
investments in property plant and equipment
-174K
-
-1.00M
475.29%
-4.36M
335.76%
-21.49M
392.71%
-4.68M
78.24%
-1.94M
58.58%
-1.00M
48.27%
-591K
41.02%
-9.57M
1,518.61%
-9.82M
2.67%
-7.97M
18.80%
acquisitions net
29.52M
-
19.90M
32.58%
-73.65M
470.12%
-92.25M
25.25%
purchases of investments
-267.76M
-
-290.59M
8.53%
-96.53M
66.78%
-21.83M
77.38%
-46.42M
112.62%
-218.28M
370.24%
-95.97M
56.03%
-48.22M
49.75%
-4.43M
90.82%
sales maturities of investments
136.39M
-
246.49M
80.73%
158.31M
35.77%
136.09M
14.04%
16.90M
87.58%
59.98M
254.85%
169.63M
182.78%
140.47M
17.19%
22.98M
83.64%
other investing activites
-10K
-
-102K
920.00%
-1.40M
1,272.55%
139K
109.93%
-113K
181.29%
-29.52M
-
-19.90M
32.58%
73.65M
470.12%
92.25M
25.25%
net cash used for investing activites
-184K
-
-1.10M
499.46%
-137.13M
12,332.73%
-65.45M
52.27%
56.99M
187.07%
112.32M
97.09%
-30.52M
127.17%
-158.89M
420.65%
64.09M
140.33%
82.43M
28.62%
10.58M
87.16%
debt repayment
-400K
-
-2.60M
550%
-25M
-
-948K
-
-1.91M
101.16%
-50.52M
2,549.08%
common stock issued
5K
-
143.01M
2,860,200%
61K
-
61.22M
100,252.46%
268.64M
338.85%
827K
99.69%
101.17M
12,133.13%
21.19M
79.06%
common stock repurchased
-24K
-
-33K
-
-197K
496.97%
dividends paid
-262K
-
other financing activites
944K
-
124.39M
13,076.59%
-2.40M
101.93%
2.14M
188.94%
116K
94.57%
404K
248.28%
50.02M
12,280.20%
34.78M
30.46%
1.30M
96.27%
30.34M
2,235.72%
101.04M
233.00%
net cash used provided by financing activities
944K
-
123.99M
13,034.75%
137.72M
11.08%
2.14M
98.45%
83K
96.12%
268K
222.89%
86.23M
32,075.75%
303.42M
251.87%
1.18M
99.61%
129.60M
10,901.87%
71.70M
44.67%
effect of forex changes on cash
-1K
-
-1K
0%
2K
300%
net change in cash
-4.56M
-
112.53M
2,567.24%
-40.25M
135.77%
-19.39M
51.82%
-18.45M
4.86%
49.73M
369.54%
-20.81M
141.84%
50.92M
344.74%
71.95M
41.30%
-16.79M
123.33%
-35.06M
108.88%
cash at beginning of period
6.21M
-
1.65M
73.39%
114.19M
6,803.57%
73.93M
35.25%
54.54M
26.23%
36.20M
33.62%
85.93M
137.38%
65.13M
24.21%
116.05M
78.19%
188.00M
62.00%
163.03M
13.28%
cash at end of period
1.65M
-
114.19M
6,803.57%
73.93M
35.25%
54.54M
26.23%
36.09M
33.83%
85.93M
138.12%
65.13M
24.21%
116.05M
78.19%
188.00M
62.00%
171.22M
8.93%
127.97M
25.26%
operating cash flow
-5.32M
-
-10.36M
94.66%
-40.84M
294.32%
43.92M
207.53%
-75.52M
271.95%
-62.85M
16.78%
-76.52M
21.74%
-93.61M
22.33%
6.69M
107.14%
-228.82M
3,521.29%
-117.35M
48.71%
capital expenditure
-174K
-
-1.00M
475.29%
-4.36M
335.76%
-21.49M
392.71%
-4.68M
78.24%
-1.94M
58.58%
-1.00M
48.27%
-591K
41.02%
-9.57M
1,518.61%
-9.82M
2.67%
-7.97M
18.80%
free cash flow
-5.50M
-
-11.36M
106.72%
-45.21M
297.98%
22.43M
149.62%
-80.20M
457.57%
-64.79M
19.21%
-77.52M
19.65%
-94.20M
21.52%
-2.88M
96.94%
-238.64M
8,191.77%
-125.33M
47.48%

All numbers in USD (except ratios and percentages)